Quelles complications peuvent survenir avec des anomalies des MAR ?
Les complications incluent des troubles du développement et un risque accru de cancers.
ComplicationsTroubles du développement
#2
Les anomalies des MAR peuvent-elles entraîner des maladies chroniques ?
Oui, certaines anomalies peuvent contribuer à des maladies chroniques comme le cancer.
Maladies chroniquesCancers
#3
Y a-t-il des complications liées aux traitements des MAR ?
Les traitements peuvent avoir des effets secondaires, mais pas spécifiquement liés aux MAR.
Effets secondairesTraitements
#4
Les complications sont-elles réversibles ?
Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes.
RéversibilitéGestion des complications
#5
Les anomalies des MAR affectent-elles la fertilité ?
Certaines anomalies peuvent influencer la fertilité, mais cela dépend du contexte génétique.
FertilitéAnomalies génétiques
Facteurs de risque
5
#1
Quels sont les facteurs de risque pour les anomalies des MAR ?
Les facteurs incluent des prédispositions génétiques et des expositions environnementales.
Facteurs de risquePrédispositions génétiques
#2
L'âge influence-t-il les anomalies des MAR ?
Oui, l'âge avancé peut augmenter le risque de mutations génétiques, y compris dans les MAR.
ÂgeMutations génétiques
#3
Le mode de vie affecte-t-il les MAR ?
Oui, des habitudes comme le tabagisme et l'alimentation peuvent influencer les MAR.
Mode de vieTabagisme
#4
Les antécédents familiaux jouent-ils un rôle ?
Oui, des antécédents familiaux de maladies génétiques peuvent augmenter le risque d'anomalies.
Antécédents familiauxMaladies génétiques
#5
Les agents environnementaux influencent-ils les MAR ?
Oui, l'exposition à des agents cancérigènes peut affecter l'intégrité des MAR.
Agents environnementauxCancers
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Régions d'ancrage à la matrice nucléaire : Questions médicales les plus fréquentes",
"headline": "Régions d'ancrage à la matrice nucléaire : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Régions d'ancrage à la matrice nucléaire : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-10",
"dateModified": "2025-04-06",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Régions d'ancrage à la matrice nucléaire"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Structures génétiques",
"url": "https://questionsmedicales.fr/mesh/D040342",
"about": {
"@type": "MedicalCondition",
"name": "Structures génétiques",
"code": {
"@type": "MedicalCode",
"code": "D040342",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Régions d'ancrage à la matrice nucléaire",
"alternateName": "Matrix Attachment Regions",
"code": {
"@type": "MedicalCode",
"code": "D045170",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Tian-Yun Wang",
"url": "https://questionsmedicales.fr/author/Tian-Yun%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry and Molecular Biology, Xinxiang Medical University, Xinxiang 453003, Henan, China."
}
},
{
"@type": "Person",
"name": "Xiao-Yin Wang",
"url": "https://questionsmedicales.fr/author/Xiao-Yin%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry and Molecular Biology, Xinxiang Medical University, Xinxiang 453003, Henan, China."
}
},
{
"@type": "Person",
"name": "Yan-Long Jia",
"url": "https://questionsmedicales.fr/author/Yan-Long%20Jia",
"affiliation": {
"@type": "Organization",
"name": "Pharmacy Collage, Xinxiang Medical University, Xinxiang 453003, Henan, China."
}
},
{
"@type": "Person",
"name": "Xiao Guo",
"url": "https://questionsmedicales.fr/author/Xiao%20Guo",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry and Molecular Biology, Xinxiang Medical University, Xinxiang 453003, Henan, China; International Joint Research Laboratory for Recombinant Pharmaceutical Protein Expression System of Henan, Xinxiang Medical University, Xinxiang 453003, Henan, China."
}
},
{
"@type": "Person",
"name": "Lubna Anis",
"url": "https://questionsmedicales.fr/author/Lubna%20Anis",
"affiliation": {
"@type": "Organization",
"name": "Owerko Centre for Children's Neurodevelopment and Mental Health, Alberta Children's Hospital Research Institute, Faculty of Nursing, University of Calgary, Calgary, AB T2N 1N4, Canada."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Language disorders in patients with striatal lesions: Deciphering the role of the striatum in language performance.",
"datePublished": "2023-06-01",
"url": "https://questionsmedicales.fr/article/37354871",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cortex.2023.04.016"
}
},
{
"@type": "ScholarlyArticle",
"name": "Access to Speech and Language Services and Service Providers for Children With Speech and Language Disorders.",
"datePublished": "2022-05-25",
"url": "https://questionsmedicales.fr/article/35613324",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1044/2022_AJSLP-21-00287"
}
},
{
"@type": "ScholarlyArticle",
"name": "Therapeutic hypnosis in a child with a written language disorder.",
"datePublished": "2022-10-05",
"url": "https://questionsmedicales.fr/article/36197740",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/00029157.2022.2108746"
}
},
{
"@type": "ScholarlyArticle",
"name": "Telepractice in the diagnosis and treatment of pediatric speech-language disorders: The opinions and experiences of speech-language pathologists.",
"datePublished": "2023-04-19",
"url": "https://questionsmedicales.fr/article/37116275",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ijporl.2023.111560"
}
},
{
"@type": "ScholarlyArticle",
"name": "Activities and participation of children with language disorders in outpatient care according to the ICF.",
"datePublished": "2023-08-04",
"url": "https://questionsmedicales.fr/article/37556703",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1590/2317-1782/20232022007pt"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes génétiques",
"item": "https://questionsmedicales.fr/mesh/D055614"
},
{
"@type": "ListItem",
"position": 3,
"name": "Structures génétiques",
"item": "https://questionsmedicales.fr/mesh/D040342"
},
{
"@type": "ListItem",
"position": 4,
"name": "Régions d'ancrage à la matrice nucléaire",
"item": "https://questionsmedicales.fr/mesh/D045170"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Régions d'ancrage à la matrice nucléaire - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Régions d'ancrage à la matrice nucléaire",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Régions d'ancrage à la matrice nucléaire",
"description": "Comment identifier les MAR dans le génome ?\nQuels tests sont utilisés pour étudier les MAR ?\nLes MAR sont-elles visibles par microscopie ?\nPeut-on détecter des mutations dans les MAR ?\nLes MAR sont-elles associées à des maladies ?",
"url": "https://questionsmedicales.fr/mesh/D045170?mesh_terms=Language+Disorders#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Régions d'ancrage à la matrice nucléaire",
"description": "Quels symptômes sont liés aux anomalies des MAR ?\nLes MAR affectent-elles l'expression génique ?\nY a-t-il des symptômes associés aux cancers liés aux MAR ?\nLes MAR influencent-elles le développement embryonnaire ?\nLes anomalies des MAR peuvent-elles causer des troubles ?",
"url": "https://questionsmedicales.fr/mesh/D045170?mesh_terms=Language+Disorders#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Régions d'ancrage à la matrice nucléaire",
"description": "Peut-on prévenir les anomalies des MAR ?\nY a-t-il des tests de dépistage pour les anomalies des MAR ?\nComment réduire le risque de cancers liés aux MAR ?\nL'alimentation influence-t-elle les MAR ?\nLes examens médicaux réguliers aident-ils ?",
"url": "https://questionsmedicales.fr/mesh/D045170?mesh_terms=Language+Disorders#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Régions d'ancrage à la matrice nucléaire",
"description": "Y a-t-il des traitements ciblant les MAR ?\nComment les thérapies géniques affectent-elles les MAR ?\nLes traitements du cancer affectent-ils les MAR ?\nPeut-on utiliser des médicaments pour moduler les MAR ?\nLes interventions chirurgicales peuvent-elles affecter les MAR ?",
"url": "https://questionsmedicales.fr/mesh/D045170?mesh_terms=Language+Disorders#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Régions d'ancrage à la matrice nucléaire",
"description": "Quelles complications peuvent survenir avec des anomalies des MAR ?\nLes anomalies des MAR peuvent-elles entraîner des maladies chroniques ?\nY a-t-il des complications liées aux traitements des MAR ?\nLes complications sont-elles réversibles ?\nLes anomalies des MAR affectent-elles la fertilité ?",
"url": "https://questionsmedicales.fr/mesh/D045170?mesh_terms=Language+Disorders#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Régions d'ancrage à la matrice nucléaire",
"description": "Quels sont les facteurs de risque pour les anomalies des MAR ?\nL'âge influence-t-il les anomalies des MAR ?\nLe mode de vie affecte-t-il les MAR ?\nLes antécédents familiaux jouent-ils un rôle ?\nLes agents environnementaux influencent-ils les MAR ?",
"url": "https://questionsmedicales.fr/mesh/D045170?mesh_terms=Language+Disorders#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment identifier les MAR dans le génome ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les MAR peuvent être identifiées par des techniques de séquençage et d'analyse bioinformatique."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour étudier les MAR ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests comme la PCR et l'hybridation in situ sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Les MAR sont-elles visibles par microscopie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les MAR ne sont pas directement visibles, mais leur effet sur la structure peut l'être."
}
},
{
"@type": "Question",
"name": "Peut-on détecter des mutations dans les MAR ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des mutations dans les MAR peuvent être détectées par séquençage ciblé."
}
},
{
"@type": "Question",
"name": "Les MAR sont-elles associées à des maladies ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines MAR peuvent être liées à des maladies génétiques ou à des cancers."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés aux anomalies des MAR ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anomalies des MAR peuvent entraîner des dysfonctionnements cellulaires, mais pas de symptômes spécifiques."
}
},
{
"@type": "Question",
"name": "Les MAR affectent-elles l'expression génique ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les MAR jouent un rôle crucial dans la régulation de l'expression génique."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes associés aux cancers liés aux MAR ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes dépendent du type de cancer, mais peuvent inclure fatigue, douleur, et perte de poids."
}
},
{
"@type": "Question",
"name": "Les MAR influencent-elles le développement embryonnaire ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les MAR sont impliquées dans la régulation des gènes essentiels au développement embryonnaire."
}
},
{
"@type": "Question",
"name": "Les anomalies des MAR peuvent-elles causer des troubles ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies peuvent contribuer à des troubles du développement ou des cancers."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les anomalies des MAR ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention est difficile, mais un mode de vie sain peut réduire les risques de maladies associées."
}
},
{
"@type": "Question",
"name": "Y a-t-il des tests de dépistage pour les anomalies des MAR ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de tests de dépistage spécifiques pour les anomalies des MAR."
}
},
{
"@type": "Question",
"name": "Comment réduire le risque de cancers liés aux MAR ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les facteurs de risque connus comme le tabagisme et l'exposition à des agents cancérigènes."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle les MAR ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut influencer l'expression génique, y compris celle des MAR."
}
},
{
"@type": "Question",
"name": "Les examens médicaux réguliers aident-ils ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des examens réguliers peuvent aider à détecter précocement des maladies associées."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements ciblant les MAR ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de traitements spécifiques ciblant les MAR."
}
},
{
"@type": "Question",
"name": "Comment les thérapies géniques affectent-elles les MAR ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les thérapies géniques peuvent modifier l'expression des gènes associés aux MAR."
}
},
{
"@type": "Question",
"name": "Les traitements du cancer affectent-ils les MAR ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains traitements du cancer peuvent influencer l'activité des MAR."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser des médicaments pour moduler les MAR ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des recherches sont en cours pour développer des médicaments modulant l'activité des MAR."
}
},
{
"@type": "Question",
"name": "Les interventions chirurgicales peuvent-elles affecter les MAR ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Indirectement, en modifiant l'environnement cellulaire, mais pas directement les MAR."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des anomalies des MAR ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des troubles du développement et un risque accru de cancers."
}
},
{
"@type": "Question",
"name": "Les anomalies des MAR peuvent-elles entraîner des maladies chroniques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines anomalies peuvent contribuer à des maladies chroniques comme le cancer."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications liées aux traitements des MAR ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements peuvent avoir des effets secondaires, mais pas spécifiquement liés aux MAR."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes."
}
},
{
"@type": "Question",
"name": "Les anomalies des MAR affectent-elles la fertilité ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines anomalies peuvent influencer la fertilité, mais cela dépend du contexte génétique."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les anomalies des MAR ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des prédispositions génétiques et des expositions environnementales."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il les anomalies des MAR ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'âge avancé peut augmenter le risque de mutations génétiques, y compris dans les MAR."
}
},
{
"@type": "Question",
"name": "Le mode de vie affecte-t-il les MAR ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des habitudes comme le tabagisme et l'alimentation peuvent influencer les MAR."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de maladies génétiques peuvent augmenter le risque d'anomalies."
}
},
{
"@type": "Question",
"name": "Les agents environnementaux influencent-ils les MAR ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des agents cancérigènes peut affecter l'intégrité des MAR."
}
}
]
}
]
}
Department of Biochemistry and Molecular Biology, Xinxiang Medical University, Xinxiang 453003, Henan, China.
International Joint Research Laboratory for Recombiant Pharmaceutical Protein Expression System of Henan, Xinxiang Medical University, Xinxiang 453003, Henan, China.
Publications dans "Régions d'ancrage à la matrice nucléaire" :
Department of Biochemistry and Molecular Biology, Xinxiang Medical University, Xinxiang 453003, Henan, China.
International Joint Research Laboratory for Recombiant Pharmaceutical Protein Expression System of Henan, Xinxiang Medical University, Xinxiang 453003, Henan, China.
Publications dans "Régions d'ancrage à la matrice nucléaire" :
Department of Biochemistry and Molecular Biology, Xinxiang Medical University, Xinxiang 453003, Henan, China; International Joint Research Laboratory for Recombinant Pharmaceutical Protein Expression System of Henan, Xinxiang Medical University, Xinxiang 453003, Henan, China.
Publications dans "Régions d'ancrage à la matrice nucléaire" :
Owerko Centre for Children's Neurodevelopment and Mental Health, Alberta Children's Hospital Research Institute, Faculty of Nursing, University of Calgary, Calgary, AB T2N 1N4, Canada.
Publications dans "Régions d'ancrage à la matrice nucléaire" :
Owerko Centre for Children's Neurodevelopment and Mental Health, Alberta Children's Hospital Research Institute, University of Calgary, Calgary, AB T2N 1N4, Canada.
Publications dans "Régions d'ancrage à la matrice nucléaire" :
Owerko Centre for Children's Neurodevelopment and Mental Health, Alberta Children's Hospital Research Institute, Departments of Pediatrics, Psychiatry, and Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 1N4, Canada.
Publications dans "Régions d'ancrage à la matrice nucléaire" :
International Joint Research Laboratory for Recombiant Pharmaceutical Protein Expression System of Henan, Xinxiang Medical University, Xinxiang 453003, Henan, China.
Publications dans "Régions d'ancrage à la matrice nucléaire" :
Department of Biochemistry and Molecular Biology, Xinxiang Medical University, Xinxiang 453003, Henan, China.
International Joint Research Laboratory for Recombiant Pharmaceutical Protein Expression System of Henan, Xinxiang Medical University, Xinxiang 453003, Henan, China.
Publications dans "Régions d'ancrage à la matrice nucléaire" :
Department of Biochemistry and Molecular Biology, Xinxiang Medical University, Xinxiang 453003, Henan, China; International Joint Research Laboratory for Recombinant Pharmaceutical Protein Expression System of Henan, Xinxiang Medical University, Xinxiang 453003, Henan, China.
Publications dans "Régions d'ancrage à la matrice nucléaire" :
State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing 100085, China.
University of Chinese Academy of Sciences, Beijing 100049, China.
Publications dans "Régions d'ancrage à la matrice nucléaire" :
The classical neural model of language refers to a cortical network involving frontal, parietal and temporal regions. However, patients with subcortical lesions of the striatum have language difficult...
The purposes of this study were to (a) examine children's access to services for their speech and language disorders during their lifetimes; (b) identify any child, disorder, and family characteristic...
Data from the 2012 National Health Interview Survey were used for this retrospective cohort study. Our sample included 491 children (ages 3;0-17;11 [years;months]) with speech disorders and 333 childr...
Approximately 75% of children with speech and language disorders had ever received services for their difficulties. Privately insured children and children with co-occurring conditions were more likel...
Most children with speech and language disorders received services. However, disparities existed by race/ethnicity, health insurance type, co-occurring diagnoses, and disorder duration (speech only). ...
https://doi.org/10.23641/asha.19799389....
Children with Attentional Deficit Hyperactivity Disorder (ADHD) frequently have low self-awareness and attentional deficits on which therapeutic hypnosis can have a positive impact. Here we investigat...
This prospective cross-sectional study aimed to investigate the opinions and experiences with telepractice (TP) of Dutch-speaking speech-language pathologists (SLPs) living in the Dutch-speaking part ...
Twenty-nine Dutch-speaking speech-language pathologists living in Flanders (age category 20-30 years: n = 16/29, 55.2%, 31-40 years: n = 10/29, 34.2%, 41-50 years: n = 2/29, 6.9%, 51-60 years: n = 1/2...
The study showed a statistically significant association between years of clinical experience of SLPs and their opinion that TP does not provide more options in a clinical setting compared to face-to-...
Expertise in multiple domains of pediatric speech-language therapy resulted in experiencing more added value of TP during the corona pandemic, possibly because of the experience of multiple different ...
To identify the main categories of the Activities and Participation component of the International Classification of Functioning, Disability, and Health and to verify the association with age, gender,...
This is an analytical and cross-sectional observational study, carried out with secondary data from 32 medical records of children with the majority male, mean age of 41.03 months, in early childhood ...
The descriptive analysis of the pre-selected categories allowed us to verify a high number of "Not informed" answers, with a higher percentage in vocal expression without speech (d331) performance (93...
Difficulties were identified in several categories of the Activities and Participation component and statistically significant associations between them and sociodemographic data and speech therapy di...
To examine the speech, language, and communication skills of school-age children with attention deficit and hyperactive disorder....
The sample of the study consists of attention deficit and hyperactivity disorder (...
SPSS program was used in the analysis of the data. Mann Whitney...
It has been concluded that language, speech, and working memory skills of children with attention deficit and hyperactivity disorder are lower than their peers with typical development. Speech and lan...
Theoretical models posit abnormalities in cortico-striatal pathways in two of the most common neurodevelopmental disorders (Developmental dyslexia, DD, and Attention deficit hyperactive disorder, ADHD...
Our results show that, relative to neurotypicals, DD individuals showed an impairment in model-free but not in model-based learning, whereas in ADHD the ability to use both model-free and model-based ...
Thus, learning impairments in DD may be linked to a selective deficit in the ability to form action-outcome associations based on previous history, whereas in ADHD some learning deficits may be relate...
The prevalence of language disorder in youth offenders far exceeds rates reported in community samples. Youth involved in the justice system are also at increased risk of a range of psychiatric disord...
To explore the co-occurrence of language disorder and anxiety and depression in youth offenders....
A systematic literature search of six databases (CINAHL, ERIC, Medline, PyscINFO, PubMED, Scopus) was conducted (September 2021) using key search terms relevant to the systematic review question. Stud...
Eight studies met the eligibility criteria. A range of measures was used to assess language abilities across samples. Only two studies directly addressed the relationship between language disorder and...
Although the results did not support a significant relationship between language disorder and internalizing mental health problems in youth offenders, the two appear to occur comorbidly as evidenced b...
What is already known on this subject The markedly high rates of language disorder in youth involved in the justice system have been widely reported. It is also known that externalizing mental health ...
To characterize changes in the functioning aspects, in the perception of children and adolescents with speech and language disorders under speech-language follow-up, using the ICF....
Descriptive, analytical and longitudinal research, with a qualitative and quantitative approach, whose sample consisted of 60 children and adolescents: 30 with speech and language disorders and 30 wit...
The use of ICF allowed characterizing changes resulting from speech-language follow-up. Participants with speech and language disorders presented a decrease in the magnitude of the qualifiers in the c...
The findings show changes in components of Body Functions, Activities and Participation, and the influence of Environmental Factors after speech-language follow-up, in the perception of the studied gr...
To evaluate the association between antibiotic use during pregnancy or early infancy and the risk of neurodevelopmental disorders in children....
Nationwide population based cohort study and sibling analysis....
Korea's National Health Insurance Service mother-child linked database, 2008-21....
All children live born between 2009 and 2020, followed up until 2021 to compare those with and without antibiotic exposure during pregnancy or early infancy (first six months of life)....
Autism spectrum disorder, intellectual disorder, language disorder, and epilepsy in children. After 1:1 propensity score matching based on many potential confounders, hazard ratios with 95% confidence...
After propensity score matching, 1 961 744 children were identified for the pregnancy analysis and 1 609 774 children were identified for the early infancy analysis. Although antibiotic exposure durin...
In this large cohort study, antibiotic exposure during pregnancy or early infancy was not associated with an increased risk of autism spectrum disorder, intellectual disorder, or language disorder in ...
